Lam Research (LRCX) Financials

$73.91 -0.61 (-0.82%)

Closing price 05/5/2025 04:00 PM Eastern

Extended Trading

$73.90 0.00 (-0.01%)

As of 05/5/2025 07:54 PM Eastern

Annual Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2015	6/26/2016	6/25/2017	6/24/2018	6/30/2019	6/28/2020	6/27/2021	6/26/2022	6/25/2023	6/30/2024
Net Income / (Loss) Attributable to Common Shareholders	656	914	1,698	2,381	2,191	2,252	3,908	4,605	4,511	3,828
Consolidated Net Income / (Loss)	656	914	1,698	2,381	2,191	2,252	3,908	4,605	4,511	3,828
Net Income / (Loss) Continuing Operations	656	914	1,698	2,381	2,191	2,252	3,908	4,605	4,511	3,828
Total Pre-Tax Income	741	960	1,812	3,152	2,447	2,575	4,371	5,193	5,109	4,360
Total Operating Income	788	1,074	1,902	3,213	2,465	2,674	4,482	5,382	5,175	4,264
Total Gross Profit	2,284	2,619	3,603	5,165	4,358	4,609	6,805	7,872	7,777	7,053
Total Revenue	5,259	5,886	8,014	11,077	9,654	10,045	14,626	17,227	17,429	14,905
Operating Revenue	5,259	5,886	8,014	11,077	9,654	10,045	14,626	17,227	17,429	14,905
Total Cost of Revenue	2,975	3,267	4,410	5,912	5,295	5,436	7,821	9,355	9,652	7,853
Operating Cost of Revenue	2,975	3,267	4,410	5,912	5,295	5,436	7,821	9,355	9,652	7,809
Total Operating Expenses	1,496	1,545	1,701	1,952	1,894	1,935	2,323	2,490	2,602	2,789
Selling, General & Admin Expense	592	631	667	762	702	682	830	886	833	868
Research & Development Expense	825	914	1,034	1,190	1,191	1,252	1,493	1,604	1,727	1,902
Total Other Income / (Expense), net	-47	-114	-90	-62	-18	-99	-111	-189	-66	96
Other Income / (Expense), net	-47	-114	-90	-62	-18	-99	-111	-189	-66	96
Income Tax Expense	85	46	114	771	255	323	462	588	598	532
Basic Earnings per Share	$4.11	$5.75	$10.47	$14.73	$14.37	$15.55	$27.22	$32.92	$33.30	$29.13
Weighted Average Basic Shares Outstanding	159.63M	158.92M	162.22M	161.64M	152.48M	144.81M	143.61M	139.90M	135.47M	131.41M
Diluted Earnings per Share	$3.70	$5.22	$9.24	$13.17	$13.70	$15.10	$26.90	$32.75	$33.21	$29.00
Weighted Average Diluted Shares Outstanding	177.07M	175.16M	183.77M	180.78M	159.92M	149.09M	145.32M	140.63M	135.83M	132.00M
Weighted Average Basic & Diluted Shares Outstanding	159.50M	159M	162.20M	161.60M	144.53M	145.63M	141.95M	136.99M	132.51M	129.88M
Cash Dividends to Common per Share	$0.84	$1.20	$1.65	$2.55	$4.40	$4.60	$5.20	$6.00	$6.90	$8.00

This table shows Lam Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/25/2022	12/25/2022	3/26/2023	6/25/2023	9/24/2023	12/24/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025
Net Income / (Loss) Attributable to Common Shareholders	1,426	1,469	814	803	887	954	966	1,020	1,116	1,191	1,331
Consolidated Net Income / (Loss)	1,426	1,469	814	803	887	954	966	1,020	1,116	1,191	1,331
Net Income / (Loss) Continuing Operations	1,426	1,469	814	803	887	954	966	1,020	1,116	1,191	1,331
Total Pre-Tax Income	1,655	1,652	939	864	1,026	1,087	1,093	1,154	1,294	1,348	1,537
Total Operating Income	1,698	1,680	942	855	1,023	1,057	1,057	1,127	1,264	1,334	1,562
Total Gross Profit	2,337	2,376	1,606	1,458	1,655	1,757	1,801	1,840	2,003	2,073	2,314
Total Revenue	5,074	5,278	3,870	3,207	3,482	3,758	3,794	3,872	4,168	4,376	4,720
Operating Revenue	5,074	5,278	3,870	3,207	3,482	3,758	3,794	3,872	4,168	4,376	4,720
Total Cost of Revenue	2,737	2,901	2,264	1,749	1,827	2,001	1,993	2,031	2,165	2,303	2,406
Operating Cost of Revenue	2,737	2,901	2,264	1,749	1,819	1,986	1,993	2,011	2,165	2,303	2,406
Total Operating Expenses	639	696	663	604	632	700	743	714	738	739	752
Selling, General & Admin Expense	206	234	194	200	207	229	216	216	243	244	226
Research & Development Expense	433	462	429	402	423	470	512	498	495	495	526
Total Other Income / (Expense), net	-43	-28	-3.33	9.01	2.60	30	36	28	30	14	-25
Other Income / (Expense), net	-43	-28	-3.33	9.01	2.60	30	36	28	30	14	-25
Income Tax Expense	229	183	125	61	138	133	127	134	178	157	206
Basic Earnings per Share	$10.42	$10.80	$6.03	$6.05	$0.67	$0.72	$7.38	$7.81	$0.86	$0.93	$1.04
Weighted Average Basic Shares Outstanding	136.89M	136.02M	134.92M	135.47M	1.33B	1.32B	130.84M	131.41M	1.30B	1.29B	1.28B
Diluted Earnings per Share	$10.39	$10.77	$6.01	$6.04	$0.67	$0.72	$7.34	$7.78	$0.86	$0.92	$1.03
Weighted Average Diluted Shares Outstanding	137.21M	136.34M	135.40M	135.83M	1.33B	1.32B	131.52M	132.00M	1.30B	1.29B	1.29B
Weighted Average Basic & Diluted Shares Outstanding	136.38M	134.94M	134.34M	132.51M	131.79M	131.10M	130.74M	129.88M	1.29B	1.28B	1.28B
Cash Dividends to Common per Share	$1.73	$1.73	$1.73	-	-	-	$2.00	-	$0.23	$0.23	$0.23

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2015	6/26/2016	6/25/2017	6/24/2018	6/30/2019	6/28/2020	6/27/2021	6/26/2022	6/25/2023	6/30/2024
Net Change in Cash & Equivalents	831	3,811	-2,656	2,135	-855	1,256	-498	-897	1,814	263
Net Cash From Operating Activities	666	1,295	2,029	2,656	3,176	2,126	3,588	3,100	5,179	4,652
Net Cash From Continuing Operating Activities	666	1,295	2,029	2,656	3,176	2,126	3,588	3,100	5,179	4,652
Net Income / (Loss) Continuing Operations	656	914	1,698	2,381	2,191	2,252	3,908	4,605	4,511	3,828
Consolidated Net Income / (Loss)	656	914	1,698	2,381	2,191	2,252	3,908	4,605	4,511	3,828
Depreciation Expense	278	291	307	326	309	269	307	334	342	360
Non-Cash Adjustments To Reconcile Net Income	148	191	166	248	189	196	203	214	339	303
Changes in Operating Assets and Liabilities, net	-415	-101	-167	-314	487	-590	-830	-2,054	-13	161
Net Cash From Investing Activities	-194	469	-2,053	2,749	-1,637	-244	73	612	-535	-371
Net Cash From Continuing Investing Activities	-194	469	-2,053	2,749	-1,637	-244	73	612	-535	-371
Purchase of Property, Plant & Equipment	-198	-175	-157	-273	-303	-203	-349	-546	-502	-397
Acquisitions	-	-	0.00	-116	-	-	0.00	0.00	-120	0.00
Purchase of Investments	-	-	-4,582	-2,533	-2,930	-2,898	-3,389	-568	0.00	0.00
Sale and/or Maturity of Investments	-	643	2,698	5,686	1,604	2,883	3,854	1,734	98	38
Other Investing Activities, net	3.98	1.64	-13	-15	-7.36	-26	-42	-7.58	-11	-12
Net Cash From Financing Activities	369	2,048	-2,632	-3,272	-2,390	-624	-4,167	-4,579	-2,831	-3,996
Net Cash From Continuing Financing Activities	369	2,048	-2,632	-3,272	-2,390	-624	-4,167	-4,579	-2,831	-3,996
Repayment of Debt	-0.66	-0.49	-1,688	-1,506	-493	-1,916	-864	-12	-27	-270
Repurchase of Common Equity	-573	-158	-812	-2,653	-3,781	-1,370	-2,698	-3,866	-2,017	-2,843
Payment of Dividends	-116	-190	-243	-308	-678	-657	-727	-815	-908	-1,019
Issuance of Common Equity	66	59	73	85	85	94	122	114	121	136
Effect of Exchange Rate Changes	-9.02	-0.72	-0.06	2.59	-4.04	-2.75	7.22	-30	0.13	-22
Cash Interest Paid	-	-	105	84	77	172	204	176	175	173
Cash Income Taxes Paid	115	40	28	143	300	223	519	808	810	992

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/25/2022	12/25/2022	3/26/2023	6/25/2023	9/24/2023	12/24/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025
Net Change in Cash & Equivalents	734	229	820	31	-461	499	48	177	221	-395	-214
Net Cash From Operating Activities	1,190	1,140	1,726	1,123	951	1,454	1,385	862	1,568	742	1,309
Net Cash From Continuing Operating Activities	1,190	1,140	1,726	1,123	951	1,454	1,385	862	1,568	742	1,309
Net Income / (Loss) Continuing Operations	1,426	1,469	814	803	887	954	966	1,020	1,116	1,191	1,331
Consolidated Net Income / (Loss)	1,426	1,469	814	803	887	954	966	1,020	1,116	1,191	1,331
Depreciation Expense	76	85	92	90	90	91	90	88	94	96	97
Non-Cash Adjustments To Reconcile Net Income	68	86	-58	242	67	74	87	75	80	73	89
Changes in Operating Assets and Liabilities, net	-380	-500	878	-12	-94	335	242	-321	278	-619	-208
Net Cash From Investing Activities	-128	-267	-84	-55	-75	-102	-92	-102	-111	-175	-293
Net Cash From Continuing Investing Activities	-128	-267	-84	-55	-75	-102	-92	-102	-111	-175	-293
Purchase of Property, Plant & Equipment	-140	-163	-119	-79	-77	-115	-104	-101	-111	-188	-288
Other Investing Activities, net	-2.44	-1.66	-4.29	-2.79	-4.97	-2.52	-3.36	-0.87	0.04	13	-4.86
Net Cash From Financing Activities	-311	-662	-820	-1,038	-1,326	-860	-1,236	-574	-1,259	-935	-1,233
Net Cash From Continuing Financing Activities	-311	-662	-820	-1,038	-1,326	-860	-1,236	-574	-1,259	-935	-1,233
Repayment of Debt	-2.34	-16	-3.61	-4.98	-255	-4.81	-0.76	-8.82	-1.26	-0.27	-504
Repurchase of Common Equity	-110	-456	-582	-869	-843	-645	-981	-374	-997	-698	-435
Payment of Dividends	-206	-236	-234	-232	-230	-264	-263	-261	-261	-298	-296
Issuance of Common Equity	6.80	46	-	68	2.82	55	8.24	70	-0.04	60	1.99
Effect of Exchange Rate Changes	-17	18	-2.30	1.48	-11	6.73	-8.45	-9.62	23	-26	2.38

This table presents Lam Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2015	6/26/2016	6/25/2017	6/24/2018	6/30/2019	6/28/2020	6/27/2021	6/26/2022	6/25/2023	6/30/2024
Total Assets	9,365	12,264	12,123	12,479	12,001	14,559	15,892	17,196	18,782	18,745
Total Current Assets	6,271	9,213	9,142	9,150	8,560	10,854	11,652	12,285	13,228	12,883
Cash & Equivalents	1,502	5,039	2,378	4,512	3,658	4,915	4,418	3,522	5,337	5,848
Accounts Receivable	1,094	1,262	1,673	2,177	1,456	2,097	3,026	4,314	2,823	2,519
Inventories, net	943	972	1,233	1,876	1,540	1,900	2,689	3,966	4,816	4,218
Prepaid Expenses	157	151	195	147	134	146	208	347	252	298
Plant, Property, & Equipment, net	621	640	686	903	0.00	0.00	0.00	1,648	1,857	2,155
Total Noncurrent Assets	2,472	2,412	2,295	2,427	3,441	3,706	4,240	3,263	3,697	3,707
Goodwill	1,388	1,386	1,386	1,485	1,485	1,484	1,490	1,515	1,622	1,765
Other Noncurrent Operating Assets	186	210	242	368	1,484	1,799	2,365	1,394	1,906	1,942
Total Liabilities & Shareholders' Equity	9,365	12,264	12,123	12,479	12,001	14,559	15,892	17,196	18,782	18,745
Total Liabilities	4,020	6,162	5,135	5,899	7,278	9,376	9,865	10,917	10,571	10,205
Total Current Liabilities	2,631	2,418	2,950	3,150	2,372	3,162	3,528	4,565	4,185	4,338
Short-Term Debt	1,360	948	908	610	667	840	11	7.38	8.36	505
Accounts Payable	300	348	465	511	377	592	830	1,011	471	614
Accrued Expenses	649	773	969	1,309	947	1,273	1,719	1,974	2,011	1,802
Current Deferred Revenue	322	349	608	720	381	458	967	-	1,695	1,418
Total Noncurrent Liabilities	1,388	3,744	2,185	2,749	4,906	6,213	6,337	6,353	6,387	5,867
Long-Term Debt	1,001	3,378	1,785	1,807	3,823	4,971	4,990	4,998	5,003	4,479
Noncurrent Deferred Revenue	203	232	120	852	893	910	948	931	882	813
Other Noncurrent Operating Liabilities	184	135	280	91	191	333	399	423	501	575
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,103	5,895	6,817	6,502	4,674	5,172	6,027	6,278	8,210	8,539
Total Preferred & Common Equity	5,103	5,895	6,817	6,502	4,674	5,172	6,027	6,278	8,210	8,539
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,103	5,895	6,817	6,502	4,674	5,172	6,027	6,278	8,210	8,539
Common Stock	5,367	5,573	5,846	6,145	6,410	6,696	7,053	7,415	7,809	8,224
Retained Earnings	4,097	4,820	6,250	8,261	9,931	11,521	14,685	18,455	22,032	24,811
Treasury Stock	-4,303	-4,429	-5,216	-7,846	-11,603	-12,950	-15,647	-19,481	-21,530	-24,366
Accumulated Other Comprehensive Income / (Loss)	-58	-69	-62	-57	-64	-94	-64	-110	-101	-130

This table presents Lam Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/25/2022	12/25/2022	3/26/2023	6/25/2023	9/24/2023	12/24/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025
Total Assets	18,721	19,206	19,243	18,782	18,538	18,784	18,280	18,745	19,532	19,840	19,968
Total Current Assets	13,613	13,709	13,730	13,228	12,994	13,055	12,488	12,883	13,492	13,613	13,460
Cash & Equivalents	4,256	4,485	5,306	5,337	5,126	5,623	5,672	5,848	6,067	5,665	5,451
Accounts Receivable	4,570	4,070	3,262	2,823	2,811	2,707	2,204	2,519	2,937	3,305	3,228
Inventories, net	4,360	4,820	4,882	4,816	4,748	4,430	4,323	4,218	4,210	4,358	4,463
Prepaid Expenses	306	231	216	252	278	279	290	298	278	284	318
Plant, Property, & Equipment, net	1,719	0.00	0.00	1,857	2,111	2,147	2,182	2,155	2,214	2,314	2,372
Total Noncurrent Assets	3,390	5,498	5,513	3,697	3,434	3,582	3,609	3,707	3,826	3,913	4,136
Goodwill	1,515	1,620	1,622	1,622	1,626	1,627	1,627	1,765	1,758	1,761	1,795
Other Noncurrent Operating Assets	1,514	3,441	3,461	1,906	1,650	1,804	1,840	1,942	2,068	2,152	2,341
Total Liabilities & Shareholders' Equity	18,721	19,206	19,243	18,782	18,538	18,784	18,280	18,745	19,532	19,840	19,968
Total Liabilities	11,309	10,902	10,836	10,571	10,491	10,561	10,258	10,205	11,061	11,032	10,457
Total Current Liabilities	5,053	4,547	4,441	4,185	4,247	4,272	4,430	4,338	5,343	5,350	5,490
Short-Term Debt	7.11	7.23	8.46	8.36	3.86	3.78	505	505	505	504	754
Accounts Payable	1,146	919	602	471	528	500	532	614	704	822	853
Accrued Expenses	1,949	2,068	1,990	2,011	2,120	1,976	1,792	1,802	2,196	2,096	2,000
Current Deferred Revenue	1,951	1,552	1,841	1,695	1,595	-	1,602	1,418	1,937	-	1,882
Total Noncurrent Liabilities	6,255	6,355	6,395	6,387	6,244	6,289	5,827	5,867	5,718	5,682	4,967
Long-Term Debt	4,996	4,996	4,997	5,003	4,980	4,980	4,478	4,479	4,479	4,478	3,730
Noncurrent Deferred Revenue	840	862	885	882	781	798	832	813	665	670	691
Other Noncurrent Operating Liabilities	419	496	512	501	483	511	517	575	574	534	547
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7,413	8,305	8,407	8,210	8,047	8,222	8,022	8,539	8,472	8,808	9,511
Total Preferred & Common Equity	7,413	8,305	8,407	8,210	8,047	8,222	8,022	8,539	8,472	8,808	9,511
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7,413	8,305	8,407	8,210	8,047	8,222	8,022	8,539	8,472	8,808	9,511
Common Stock	7,493	7,606	7,680	7,809	7,879	7,997	8,082	8,224	8,304	8,441	8,530
Retained Earnings	19,645	20,879	21,460	22,032	22,655	23,347	24,052	24,811	25,630	26,525	27,561
Treasury Stock	-19,591	-20,072	-20,628	-21,530	-22,366	-23,004	-23,985	-24,366	-25,375	-26,024	-26,456
Accumulated Other Comprehensive Income / (Loss)	-134	-109	-105	-101	-121	-118	-128	-130	-88	-134	-124

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2015	6/26/2016	6/25/2017	6/24/2018	6/30/2019	6/28/2020	6/27/2021	6/26/2022	6/25/2023	6/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.15%	11.91%	36.15%	38.23%	-12.85%	4.05%	45.61%	17.78%	1.17%	-14.48%
EBITDA Growth	0.31%	22.81%	71.35%	62.91%	-21.09%	3.18%	64.51%	18.15%	-1.36%	-13.42%
EBIT Growth	2.42%	29.60%	88.69%	73.97%	-22.38%	5.25%	69.74%	18.81%	-1.62%	-14.66%
NOPAT Growth	17.72%	46.66%	74.29%	36.16%	-9.04%	5.91%	71.41%	19.08%	-4.27%	-18.07%
Net Income Growth	3.68%	39.43%	85.74%	40.22%	-7.95%	2.75%	73.57%	17.83%	-2.05%	-15.14%
EPS Growth	2.21%	41.08%	77.01%	42.53%	4.02%	10.22%	78.15%	21.75%	1.40%	-12.68%
Operating Cash Flow Growth	-11.54%	94.38%	56.70%	30.87%	19.59%	-33.05%	68.74%	-13.61%	67.08%	-10.17%
Free Cash Flow Firm Growth	0.58%	96.74%	54.53%	15.50%	22.37%	-25.76%	62.99%	-18.25%	66.02%	-2.62%
Invested Capital Growth	3.66%	-3.15%	1.01%	12.04%	-6.96%	14.27%	25.24%	46.12%	6.91%	-2.66%
Revenue Q/Q Growth	4.63%	1.11%	11.07%	7.59%	-7.34%	4.48%	10.20%	2.93%	-7.57%	4.66%
EBITDA Q/Q Growth	-10.52%	10.23%	19.57%	11.34%	-11.96%	5.35%	13.82%	1.09%	-8.30%	6.53%
EBIT Q/Q Growth	-13.82%	13.11%	21.57%	12.68%	-12.48%	5.70%	14.71%	0.98%	-8.84%	7.14%
NOPAT Q/Q Growth	-2.67%	15.46%	15.83%	25.60%	-17.56%	7.15%	12.52%	3.58%	-10.21%	5.70%
Net Income Q/Q Growth	-13.48%	16.23%	18.70%	26.23%	-17.95%	7.38%	12.95%	1.42%	-8.26%	6.03%
EPS Q/Q Growth	-12.94%	16.00%	17.86%	27.37%	-13.84%	8.71%	13.69%	2.50%	-7.52%	6.38%
Operating Cash Flow Q/Q Growth	-40.88%	57.34%	30.34%	-1.75%	5.38%	-3.07%	21.01%	-24.24%	15.08%	-5.30%
Free Cash Flow Firm Q/Q Growth	-7.48%	24.23%	11.70%	-1.43%	7.44%	-4.37%	24.56%	-26.52%	8.97%	-1.19%
Invested Capital Q/Q Growth	-1.63%	-4.05%	-2.33%	13.24%	-5.32%	1.05%	-1.98%	14.71%	1.18%	4.66%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.43%	44.49%	44.97%	46.63%	45.15%	45.88%	46.53%	45.69%	44.62%	47.32%
EBITDA Margin	19.37%	21.26%	26.75%	31.53%	28.55%	28.31%	31.98%	32.08%	31.28%	31.67%
Operating Margin	14.98%	18.25%	23.74%	29.01%	25.53%	26.62%	30.64%	31.24%	29.69%	28.61%
EBIT Margin	14.09%	16.31%	22.61%	28.45%	25.34%	25.64%	29.88%	30.15%	29.32%	29.25%
Profit (Net Income) Margin	12.47%	15.53%	21.19%	21.49%	22.70%	22.42%	26.72%	26.73%	25.88%	25.68%
Tax Burden Percent	88.49%	95.20%	93.71%	75.53%	89.57%	87.45%	89.42%	88.68%	88.29%	87.79%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	11.51%	4.80%	6.29%	24.47%	10.43%	12.55%	10.58%	11.32%	11.71%	12.21%
Return on Invested Capital (ROIC)	20.53%	30.04%	52.95%	67.66%	60.34%	61.88%	88.31%	76.84%	59.88%	48.11%
ROIC Less NNEP Spread (ROIC-NNEP)	22.74%	34.73%	55.62%	69.12%	61.16%	69.24%	97.63%	-210.15%	44.85%	33.91%
Return on Net Nonoperating Assets (RNNOA)	-8.11%	-14.07%	-27.01%	-32.57%	-21.56%	-16.42%	-18.58%	-1.99%	2.39%	-2.41%
Return on Equity (ROE)	12.42%	15.97%	25.94%	35.09%	38.77%	45.46%	69.73%	74.85%	62.27%	45.71%
Cash Return on Invested Capital (CROIC)	16.93%	33.24%	51.95%	56.31%	67.55%	48.56%	65.89%	39.36%	53.20%	50.81%
Operating Return on Assets (OROA)	8.54%	8.88%	14.86%	25.62%	19.99%	19.39%	28.71%	31.39%	28.40%	23.24%
Return on Assets (ROA)	7.55%	8.45%	13.92%	19.35%	17.90%	16.96%	25.67%	27.84%	25.08%	20.40%
Return on Common Equity (ROCE)	11.92%	15.34%	25.19%	34.45%	38.34%	45.18%	69.66%	74.85%	62.27%	45.71%
Return on Equity Simple (ROE_SIMPLE)	12.85%	15.51%	24.90%	36.62%	46.89%	43.53%	64.85%	73.35%	54.94%	44.82%
Net Operating Profit after Tax (NOPAT)	697	1,023	1,783	2,427	2,208	2,338	4,008	4,773	4,569	3,743
NOPAT Margin	13.26%	17.38%	22.24%	21.91%	22.87%	23.28%	27.40%	27.70%	26.22%	25.11%
Net Nonoperating Expense Percent (NNEP)	-2.22%	-4.68%	-2.67%	-1.45%	-0.82%	-7.36%	-9.32%	286.99%	15.03%	14.21%
Cost of Revenue to Revenue	56.57%	55.51%	55.03%	53.37%	54.85%	54.12%	53.47%	54.31%	55.38%	52.68%
SG&A Expenses to Revenue	11.25%	10.72%	8.33%	6.88%	7.28%	6.79%	5.67%	5.14%	4.78%	5.83%
R&D to Revenue	15.69%	15.52%	12.90%	10.74%	12.34%	12.47%	10.21%	9.31%	9.91%	12.76%
Operating Expenses to Revenue	28.45%	26.24%	21.23%	17.62%	19.62%	19.26%	15.88%	14.45%	14.93%	18.71%
Earnings before Interest and Taxes (EBIT)	741	960	1,812	3,152	2,447	2,575	4,371	5,193	5,109	4,360
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,019	1,251	2,144	3,493	2,756	2,844	4,678	5,527	5,452	4,720
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.25	1.98	3.24	4.03	5.65	8.11	14.41	9.71	9.86	16.30
Price to Tangible Book Value (P/TBV)	3.84	2.96	4.39	5.57	8.88	11.92	19.71	13.08	12.62	20.55
Price to Revenue (P/Rev)	2.18	1.98	2.75	2.36	2.73	4.18	5.94	3.54	4.65	9.34
Price to Earnings (P/E)	17.50	12.76	13.00	10.99	12.04	18.63	22.22	13.24	17.95	36.37
Dividend Yield	1.16%	1.64%	1.21%	1.60%	2.50%	1.59%	0.85%	1.36%	1.14%	0.75%
Earnings Yield	5.71%	7.83%	7.69%	9.10%	8.30%	5.37%	4.50%	7.55%	5.57%	2.75%
Enterprise Value to Invested Capital (EV/IC)	2.84	2.72	5.51	6.19	7.16	10.13	17.01	8.42	10.23	18.03
Enterprise Value to Revenue (EV/Rev)	1.87	1.55	2.32	2.12	2.61	4.06	5.87	3.60	4.63	9.28
Enterprise Value to EBITDA (EV/EBITDA)	9.65	7.29	8.69	6.72	9.16	14.35	18.35	11.23	14.80	29.31
Enterprise Value to EBIT (EV/EBIT)	13.27	9.50	10.28	7.44	10.32	15.85	19.64	11.95	15.79	31.73
Enterprise Value to NOPAT (EV/NOPAT)	14.09	8.92	10.45	9.67	11.43	17.45	21.42	13.01	17.65	36.96
Enterprise Value to Operating Cash Flow (EV/OCF)	14.75	7.04	9.18	8.83	7.95	19.19	23.93	20.03	15.57	29.74
Enterprise Value to Free Cash Flow (EV/FCFF)	17.09	8.06	10.65	11.62	10.21	22.24	28.70	25.39	19.87	35.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.44	0.71	0.39	0.37	0.95	1.12	0.83	0.80	0.61	0.58
Long-Term Debt to Equity	0.19	0.55	0.26	0.27	0.81	0.96	0.83	0.80	0.61	0.52
Financial Leverage	-0.36	-0.41	-0.49	-0.47	-0.35	-0.24	-0.19	0.01	0.05	-0.07
Leverage Ratio	1.64	1.89	1.86	1.81	2.17	2.68	2.72	2.69	2.48	2.24
Compound Leverage Factor	1.64	1.89	1.86	1.81	2.17	2.68	2.72	2.69	2.48	2.24
Debt to Total Capital	30.64%	41.48%	27.82%	26.86%	48.73%	52.85%	45.35%	44.36%	37.90%	36.85%
Short-Term Debt to Total Capital	17.64%	9.09%	9.38%	6.78%	7.24%	7.64%	0.10%	0.07%	0.06%	3.73%
Long-Term Debt to Total Capital	12.99%	32.40%	18.44%	20.08%	41.49%	45.21%	45.25%	44.30%	37.84%	33.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.14%	1.99%	1.75%	0.87%	0.54%	0.10%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.22%	56.53%	70.42%	72.27%	50.73%	47.05%	54.65%	55.64%	62.10%	63.15%
Debt to EBITDA	2.32	3.46	1.26	0.69	1.63	2.04	1.07	0.91	0.92	1.06
Net Debt to EBITDA	-1.85	-2.20	-1.68	-0.80	-0.43	-0.41	-0.21	0.20	-0.06	-0.18
Long-Term Debt to EBITDA	0.98	2.70	0.83	0.52	1.39	1.75	1.07	0.90	0.92	0.95
Debt to NOPAT	3.39	4.23	1.51	1.00	2.03	2.49	1.25	1.05	1.10	1.33
Net Debt to NOPAT	-2.71	-2.69	-2.02	-1.15	-0.54	-0.49	-0.24	0.23	-0.07	-0.23
Long-Term Debt to NOPAT	1.44	3.30	1.00	0.74	1.73	2.13	1.25	1.05	1.10	1.20
Altman Z-Score	3.61	3.09	5.07	5.89	5.43	5.70	9.02	7.39	8.64	12.15
Noncontrolling Interest Sharing Ratio	4.03%	3.93%	2.88%	1.83%	1.13%	0.61%	0.10%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.38	3.81	3.10	2.90	3.61	3.43	3.30	2.69	3.16	2.97
Quick Ratio	1.96	3.35	2.62	2.26	2.90	2.79	2.48	1.75	1.95	1.93
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	575	1,132	1,749	2,020	2,472	1,835	2,991	2,445	4,059	3,953
Operating Cash Flow to CapEx	336.02%	738.60%	1,299.76%	971.13%	1,046.49%	1,046.28%	1,027.84%	567.67%	1,032.55%	1,172.83%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.54	0.66	0.90	0.79	0.76	0.96	1.04	0.97	0.79
Accounts Receivable Turnover	5.55	5.00	5.46	5.75	5.32	5.65	5.71	4.69	4.88	5.58
Inventory Turnover	3.53	3.41	4.00	3.80	3.10	3.16	3.41	2.81	2.20	1.74
Fixed Asset Turnover	9.03	9.34	12.09	13.95	0.00	0.00	0.00	0.00	9.95	7.43
Accounts Payable Turnover	11.36	10.08	10.85	12.12	11.93	11.22	11.00	10.16	13.03	14.48
Days Sales Outstanding (DSO)	65.73	73.04	66.85	63.44	68.67	64.55	63.93	77.76	74.74	65.41
Days Inventory Outstanding (DIO)	103.30	106.99	91.24	95.98	117.75	115.49	107.09	129.84	166.07	209.96
Days Payable Outstanding (DPO)	32.13	36.22	33.64	30.12	30.59	32.53	33.18	35.91	28.02	25.21
Cash Conversion Cycle (CCC)	136.90	143.81	124.45	129.30	155.83	147.51	137.84	171.68	212.78	250.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,459	3,350	3,383	3,791	3,527	4,030	5,047	7,375	7,885	7,675
Invested Capital Turnover	1.55	1.73	2.38	3.09	2.64	2.66	3.22	2.77	2.28	1.92
Increase / (Decrease) in Invested Capital	122	-109	34	407	-264	503	1,017	2,328	510	-210
Enterprise Value (EV)	9,829	9,122	18,631	23,463	25,242	40,807	85,847	62,081	80,661	138,355
Market Capitalization	11,473	11,667	22,065	26,174	26,389	41,949	86,827	60,984	80,987	139,220
Book Value per Share	$32.23	$36.93	$42.26	$39.63	$31.17	$35.63	$42.26	$45.26	$61.11	$65.32
Tangible Book Value per Share	$18.87	$24.71	$31.12	$28.65	$19.83	$24.25	$30.88	$33.60	$47.78	$51.82
Total Capital	7,706	10,428	9,681	8,997	9,213	10,994	11,029	11,284	13,222	13,523
Total Debt	2,361	4,326	2,693	2,417	4,490	5,811	5,002	5,006	5,012	4,983
Total Long-Term Debt	1,001	3,378	1,785	1,807	3,823	4,971	4,990	4,998	5,003	4,479
Net Debt	-1,886	-2,752	-3,604	-2,789	-1,196	-1,153	-980	1,097	-326	-865
Capital Expenditures (CapEx)	198	175	156	273	303	203	349	546	502	397
Debt-free, Cash-free Net Working Capital (DFCFNWC)	923	915	1,060	1,660	1,425	1,821	2,407	4,070	3,715	3,202
Debt-free Net Working Capital (DFNWC)	4,999	7,743	7,101	6,610	6,856	8,531	8,136	7,728	9,052	9,050
Net Working Capital (NWC)	3,639	6,795	6,192	6,000	6,189	7,691	8,125	7,720	9,043	8,545
Net Nonoperating Expense (NNE)	42	109	85	46	16	86	99	167	58	-85
Net Nonoperating Obligations (NNO)	-1,886	-2,752	-3,604	-2,789	-1,196	-1,153	-980	1,097	-326	-865
Total Depreciation and Amortization (D&A)	278	291	332	341	309	269	307	334	342	360
Debt-free, Cash-free Net Working Capital to Revenue	17.54%	15.54%	13.22%	14.99%	14.76%	18.13%	16.46%	23.63%	21.31%	21.48%
Debt-free Net Working Capital to Revenue	95.05%	131.55%	88.61%	59.67%	71.02%	84.93%	55.63%	44.86%	51.94%	60.71%
Net Working Capital to Revenue	69.20%	115.45%	77.27%	54.16%	64.11%	76.57%	55.55%	44.82%	51.89%	57.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.11	$5.75	$10.47	$14.73	$14.37	$15.55	$27.22	$32.92	$33.30	$29.13
Adjusted Weighted Average Basic Shares Outstanding	159.63M	158.92M	162.22M	161.64M	152.48M	144.81M	143.61M	139.90M	135.47M	131.41M
Adjusted Diluted Earnings per Share	$3.70	$5.22	$9.24	$13.17	$13.70	$15.10	$26.90	$32.75	$33.21	$29.00
Adjusted Weighted Average Diluted Shares Outstanding	177.07M	175.16M	183.77M	180.78M	159.92M	149.09M	145.32M	140.63M	135.83M	132.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	158.19M	160.26M	162.45M	157.58M	144.53M	145.63M	141.95M	136.99M	132.51M	129.88M
Normalized Net Operating Profit after Tax (NOPAT)	768	1,023	1,783	2,427	2,208	2,338	4,008	4,773	4,606	3,743
Normalized NOPAT Margin	14.60%	17.38%	22.24%	21.91%	22.87%	23.28%	27.40%	27.70%	26.43%	25.11%
Pre Tax Income Margin	14.09%	16.31%	22.61%	28.45%	25.34%	25.64%	29.88%	30.15%	29.32%	29.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.70%	20.83%	14.34%	12.92%	30.95%	29.17%	18.60%	17.70%	20.13%	26.62%
Augmented Payout Ratio	105.14%	38.16%	62.15%	124.37%	203.47%	90.00%	87.62%	101.64%	64.84%	100.89%

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/25/2022	12/25/2022	3/26/2023	6/25/2023	9/24/2023	12/24/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.88%	24.87%	-4.70%	-30.81%	-31.38%	-28.79%	-1.96%	20.71%	19.70%	16.44%	24.43%
EBITDA Growth	21.59%	20.83%	-15.45%	-34.12%	-35.50%	-32.20%	14.80%	30.37%	24.41%	22.61%	38.12%
EBIT Growth	23.18%	21.81%	-17.25%	-36.45%	-38.02%	-34.20%	16.43%	33.67%	26.19%	24.02%	40.57%
NOPAT Growth	21.40%	26.69%	-23.90%	-39.66%	-39.50%	-37.86%	14.33%	25.38%	23.20%	26.97%	44.80%
Net Income Growth	20.86%	22.91%	-20.33%	-33.62%	-37.76%	-35.02%	18.65%	27.13%	25.81%	24.81%	37.78%
EPS Growth	25.63%	27.61%	-17.67%	-30.89%	-37.76%	-35.02%	22.13%	28.81%	25.81%	27.78%	41.10%
Operating Cash Flow Growth	160.01%	-20.85%	127.85%	152.90%	-20.04%	27.51%	-19.79%	-23.18%	64.90%	-48.97%	-5.50%
Free Cash Flow Firm Growth	8.08%	-431.08%	-164.62%	128.12%	314.17%	268.53%	354.85%	323.80%	97.59%	-66.00%	-89.88%
Invested Capital Growth	30.84%	43.78%	21.21%	6.91%	1.12%	-10.63%	-5.89%	-2.66%	-6.18%	7.36%	16.52%
Revenue Q/Q Growth	9.46%	4.01%	-26.68%	-17.12%	8.57%	7.93%	0.94%	2.05%	7.66%	4.99%	7.86%
EBITDA Q/Q Growth	19.61%	0.40%	-40.68%	-7.51%	17.09%	5.54%	0.43%	5.04%	11.74%	4.02%	13.14%
EBIT Q/Q Growth	21.77%	-0.17%	-43.16%	-8.02%	18.76%	5.99%	0.56%	5.60%	12.12%	4.16%	13.99%
NOPAT Q/Q Growth	11.16%	2.09%	-45.31%	-2.78%	11.46%	4.85%	0.63%	6.61%	9.52%	8.06%	14.76%
Net Income Q/Q Growth	17.95%	2.99%	-44.57%	-1.41%	10.57%	7.54%	1.21%	5.64%	9.43%	6.68%	11.73%
EPS Q/Q Growth	18.88%	3.66%	-44.20%	0.50%	10.57%	7.54%	1.66%	5.99%	9.43%	6.98%	11.96%
Operating Cash Flow Q/Q Growth	167.97%	-4.15%	51.42%	-34.97%	-15.28%	52.85%	-4.75%	-37.72%	81.87%	-52.70%	76.38%
Free Cash Flow Firm Q/Q Growth	63.16%	-191.11%	49.62%	152.03%	180.64%	129.07%	-23.81%	-13.48%	30.84%	-60.58%	-77.33%
Invested Capital Q/Q Growth	5.60%	8.74%	-7.98%	1.18%	-0.12%	-3.89%	-3.10%	4.66%	-3.74%	9.97%	5.17%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.05%	45.03%	41.49%	45.46%	47.52%	46.76%	47.46%	47.53%	48.05%	47.37%	49.02%
EBITDA Margin	34.10%	32.92%	26.63%	29.72%	32.05%	31.34%	31.19%	32.10%	33.32%	33.01%	34.62%
Operating Margin	33.46%	31.84%	24.35%	26.65%	29.38%	28.13%	27.87%	29.10%	30.33%	30.48%	33.09%
EBIT Margin	32.61%	31.30%	24.26%	26.93%	29.45%	28.92%	28.82%	29.82%	31.05%	30.81%	32.56%
Profit (Net Income) Margin	28.10%	27.83%	21.04%	25.02%	25.48%	25.39%	25.46%	26.35%	26.79%	27.22%	28.19%
Tax Burden Percent	86.17%	88.90%	86.70%	92.93%	86.52%	87.78%	88.35%	88.39%	86.26%	88.34%	86.59%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	13.83%	11.10%	13.30%	7.07%	13.48%	12.22%	11.65%	11.61%	13.74%	11.66%	13.41%
Return on Invested Capital (ROIC)	75.53%	75.09%	55.98%	56.56%	51.40%	44.09%	46.36%	49.28%	53.45%	55.63%	61.84%
ROIC Less NNEP Spread (ROIC-NNEP)	60.90%	86.99%	58.70%	58.73%	53.62%	33.40%	41.47%	45.15%	49.32%	53.74%	64.46%
Return on Net Nonoperating Assets (RNNOA)	2.34%	-2.48%	-0.86%	3.13%	0.70%	-0.99%	-3.29%	-3.21%	-3.75%	-4.22%	-6.09%
Return on Equity (ROE)	77.87%	72.60%	55.12%	59.69%	52.11%	43.10%	43.07%	46.07%	49.70%	51.41%	55.75%
Cash Return on Invested Capital (CROIC)	46.50%	38.54%	52.38%	53.20%	49.84%	53.94%	52.90%	50.81%	58.12%	46.41%	42.90%
Operating Return on Assets (OROA)	34.23%	33.22%	25.54%	26.09%	25.04%	21.80%	21.87%	23.69%	25.43%	25.86%	29.17%
Return on Assets (ROA)	29.50%	29.53%	22.14%	24.24%	21.66%	19.14%	19.33%	20.94%	21.94%	22.84%	25.26%
Return on Common Equity (ROCE)	77.87%	72.60%	55.12%	59.69%	52.11%	43.10%	43.07%	46.07%	49.70%	51.41%	55.75%
Return on Equity Simple (ROE_SIMPLE)	65.45%	61.71%	58.49%	0.00%	49.36%	42.06%	45.00%	0.00%	47.89%	48.75%	48.98%
Net Operating Profit after Tax (NOPAT)	1,463	1,494	817	794	885	928	934	996	1,090	1,178	1,352
NOPAT Margin	28.83%	28.30%	21.11%	24.76%	25.42%	24.69%	24.62%	25.72%	26.16%	26.93%	28.65%
Net Nonoperating Expense Percent (NNEP)	14.63%	-11.91%	-2.72%	-2.17%	-2.22%	10.69%	4.89%	4.13%	4.13%	1.88%	-2.62%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	7.03%	-	-	-	8.55%	9.66%
Cost of Revenue to Revenue	53.95%	54.97%	58.51%	54.54%	52.48%	53.24%	52.54%	52.47%	51.95%	52.63%	50.98%
SG&A Expenses to Revenue	4.05%	4.43%	5.00%	6.23%	5.95%	6.09%	5.69%	5.59%	5.83%	5.58%	4.79%
R&D to Revenue	8.54%	8.76%	11.10%	12.53%	12.14%	12.50%	13.50%	12.86%	11.88%	11.31%	11.14%
Operating Expenses to Revenue	12.59%	13.19%	17.14%	18.82%	18.14%	18.63%	19.60%	18.43%	17.72%	16.89%	15.93%
Earnings before Interest and Taxes (EBIT)	1,655	1,652	939	864	1,026	1,087	1,093	1,154	1,294	1,348	1,537
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,730	1,737	1,031	953	1,116	1,178	1,183	1,243	1,389	1,444	1,634
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.89	6.66	7.96	9.86	10.10	12.38	15.85	16.30	12.68	10.72	9.80
Price to Tangible Book Value (P/TBV)	8.83	8.51	10.13	12.62	12.97	15.79	20.33	20.55	16.00	13.40	12.08
Price to Revenue (P/Rev)	2.84	2.90	3.55	4.65	5.13	7.11	8.93	9.34	6.89	5.83	5.44
Price to Earnings (P/E)	10.53	10.79	13.61	17.95	20.45	29.43	35.22	36.37	26.48	22.00	20.01
Dividend Yield	2.07%	1.59%	1.35%	1.14%	1.17%	0.96%	0.80%	0.75%	1.00%	1.17%	1.23%
Earnings Yield	9.49%	9.27%	7.35%	5.57%	4.89%	3.40%	2.84%	2.75%	3.78%	4.55%	5.00%
Enterprise Value to Invested Capital (EV/IC)	6.61	6.55	8.51	10.23	10.29	13.36	17.24	18.03	14.39	11.54	10.80
Enterprise Value to Revenue (EV/Rev)	2.86	2.91	3.52	4.63	5.12	7.06	8.88	9.28	6.82	5.78	5.38
Enterprise Value to EBITDA (EV/EBITDA)	8.82	9.04	11.15	14.80	16.76	23.63	28.54	29.31	21.30	17.83	16.16
Enterprise Value to EBIT (EV/EBIT)	9.35	9.56	11.83	15.79	18.10	25.82	31.07	31.73	22.97	19.17	17.29
Enterprise Value to NOPAT (EV/NOPAT)	10.23	10.38	13.03	17.65	20.32	29.52	35.71	36.96	26.93	22.33	19.98
Enterprise Value to Operating Cash Flow (EV/OCF)	13.44	15.71	14.73	15.57	16.41	19.24	25.74	29.74	20.18	20.57	20.58
Enterprise Value to Free Cash Flow (EV/FCFF)	16.12	20.05	17.80	19.87	20.77	23.38	31.61	35.00	23.98	25.74	27.08
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.68	0.60	0.60	0.61	0.62	0.61	0.62	0.58	0.59	0.57	0.47
Long-Term Debt to Equity	0.67	0.60	0.59	0.61	0.62	0.61	0.56	0.52	0.53	0.51	0.39
Financial Leverage	0.04	-0.03	-0.01	0.05	0.01	-0.03	-0.08	-0.07	-0.08	-0.08	-0.09
Leverage Ratio	2.59	2.43	2.48	2.48	2.41	2.30	2.28	2.24	2.30	2.27	2.18
Compound Leverage Factor	2.59	2.43	2.48	2.48	2.41	2.30	2.28	2.24	2.30	2.27	2.18
Debt to Total Capital	40.30%	37.60%	37.32%	37.90%	38.25%	37.74%	38.32%	36.85%	37.04%	36.13%	32.04%
Short-Term Debt to Total Capital	0.06%	0.05%	0.06%	0.06%	0.03%	0.03%	3.88%	3.73%	3.75%	3.66%	5.39%
Long-Term Debt to Total Capital	40.24%	37.54%	37.26%	37.84%	38.22%	37.71%	34.43%	33.12%	33.29%	32.47%	26.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	59.70%	62.40%	62.68%	62.10%	61.75%	62.26%	61.68%	63.15%	62.96%	63.87%	67.96%
Debt to EBITDA	0.86	0.82	0.84	0.92	1.03	1.17	1.12	1.06	1.00	0.95	0.79
Net Debt to EBITDA	0.06	0.03	-0.10	-0.06	-0.04	-0.15	-0.16	-0.18	-0.22	-0.13	-0.17
Long-Term Debt to EBITDA	0.86	0.81	0.84	0.92	1.03	1.16	1.01	0.95	0.90	0.85	0.65
Debt to NOPAT	0.99	0.94	0.98	1.10	1.25	1.46	1.41	1.33	1.26	1.19	0.97
Net Debt to NOPAT	0.07	0.03	-0.12	-0.07	-0.04	-0.19	-0.19	-0.23	-0.27	-0.16	-0.21
Long-Term Debt to NOPAT	0.99	0.93	0.98	1.10	1.25	1.45	1.26	1.20	1.13	1.07	0.81
Altman Z-Score	5.98	6.41	6.99	7.90	7.96	9.04	10.78	11.58	9.18	8.55	8.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.69	3.02	3.09	3.16	3.06	3.06	2.82	2.97	2.53	2.54	2.45
Quick Ratio	1.77	1.90	1.94	1.95	1.88	1.95	1.78	1.93	1.69	1.68	1.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-373	-1,085	-547	284	798	1,829	1,393	1,205	1,577	622	141
Operating Cash Flow to CapEx	849.32%	697.88%	1,445.24%	1,427.13%	1,235.41%	1,261.18%	1,336.02%	856.03%	1,418.30%	393.92%	454.31%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.05	1.06	1.05	0.97	0.85	0.75	0.76	0.79	0.82	0.84	0.90
Accounts Receivable Turnover	4.52	5.10	5.42	4.88	4.29	4.22	5.21	5.58	5.42	5.39	6.31
Inventory Turnover	2.70	2.64	2.50	2.20	1.92	1.70	1.64	1.74	1.83	1.93	2.03
Fixed Asset Turnover	0.00	0.00	0.00	9.95	8.27	0.00	0.00	7.43	7.21	7.27	7.53
Accounts Payable Turnover	9.84	11.13	12.97	13.03	10.44	11.05	13.36	14.48	13.29	12.85	12.86
Days Sales Outstanding (DSO)	80.79	71.60	67.40	74.74	85.06	86.39	70.04	65.41	67.28	67.69	57.85
Days Inventory Outstanding (DIO)	135.17	138.30	146.20	166.07	190.15	215.28	221.91	209.96	199.59	188.85	180.04
Days Payable Outstanding (DPO)	37.08	32.80	28.13	28.02	34.96	33.03	27.33	25.21	27.46	28.41	28.38
Cash Conversion Cycle (CCC)	178.88	177.10	185.47	212.78	240.25	268.65	264.62	250.17	239.42	228.13	209.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,788	8,469	7,793	7,885	7,875	7,568	7,333	7,675	7,388	8,125	8,545
Invested Capital Turnover	2.62	2.65	2.65	2.28	2.02	1.79	1.88	1.92	2.04	2.07	2.16
Increase / (Decrease) in Invested Capital	1,836	2,579	1,364	510	87	-900	-459	-210	-487	557	1,211
Enterprise Value (EV)	51,483	55,469	66,289	80,661	81,069	101,107	126,449	138,355	106,339	93,760	92,240
Market Capitalization	51,107	55,305	66,904	80,987	81,241	101,761	127,138	139,220	107,423	94,443	93,207
Book Value per Share	$54.11	$60.89	$62.31	$61.11	$60.73	$62.39	$61.19	$65.32	$65.23	$6.85	$7.41
Tangible Book Value per Share	$42.25	$47.66	$48.95	$47.78	$47.27	$48.90	$47.70	$51.82	$51.69	$5.48	$6.01
Total Capital	12,416	13,308	13,413	13,222	13,032	13,206	13,006	13,523	13,456	13,790	13,995
Total Debt	5,003	5,003	5,005	5,012	4,984	4,984	4,983	4,983	4,984	4,982	4,484
Total Long-Term Debt	4,996	4,996	4,997	5,003	4,980	4,980	4,478	4,479	4,479	4,478	3,730
Net Debt	375	164	-615	-326	-172	-654	-689	-865	-1,084	-683	-966
Capital Expenditures (CapEx)	140	163	119	79	77	115	104	101	111	188	288
Debt-free, Cash-free Net Working Capital (DFCFNWC)	4,189	4,581	3,928	3,715	3,594	3,148	2,891	3,202	2,587	3,101	3,274
Debt-free Net Working Capital (DFNWC)	8,566	9,169	9,297	9,052	8,750	8,786	8,563	9,050	8,654	8,767	8,725
Net Working Capital (NWC)	8,559	9,162	9,289	9,043	8,746	8,782	8,058	8,545	8,150	8,263	7,970
Net Nonoperating Expense (NNE)	37	25	2.89	-8.37	-2.25	-26	-32	-25	-26	-13	22
Net Nonoperating Obligations (NNO)	375	164	-615	-326	-172	-654	-689	-865	-1,084	-683	-966
Total Depreciation and Amortization (D&A)	76	85	92	90	90	91	90	88	94	96	97
Debt-free, Cash-free Net Working Capital to Revenue	23.28%	24.05%	20.83%	21.31%	22.69%	21.99%	20.30%	21.48%	16.59%	19.13%	19.11%
Debt-free Net Working Capital to Revenue	47.60%	48.14%	49.30%	51.94%	55.25%	61.37%	60.13%	60.71%	55.51%	54.09%	50.92%
Net Working Capital to Revenue	47.56%	48.10%	49.26%	51.89%	55.23%	61.34%	56.59%	57.33%	52.27%	50.97%	46.51%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$10.42	$10.80	$6.03	$6.05	$0.67	$0.73	$7.38	$7.81	$0.86	$0.93	$1.04
Adjusted Weighted Average Basic Shares Outstanding	136.89M	136.02M	134.92M	135.47M	1.33B	1.32B	130.84M	131.41M	1.30B	1.29B	1.28B
Adjusted Diluted Earnings per Share	$10.39	$10.77	$6.01	$6.04	$0.67	$0.72	$7.34	$7.78	$0.86	$0.92	$1.03
Adjusted Weighted Average Diluted Shares Outstanding	137.21M	136.34M	135.40M	135.83M	1.33B	1.32B	131.52M	132.00M	1.30B	1.29B	1.29B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	136.38M	134.94M	134.34M	132.51M	1.32B	1.31B	130.74M	129.88M	1.29B	1.28B	1.28B
Normalized Net Operating Profit after Tax (NOPAT)	1,463	1,494	852	794	885	928	947	996	1,090	1,178	1,352
Normalized NOPAT Margin	28.83%	28.30%	22.02%	24.76%	25.42%	24.69%	24.97%	25.72%	26.16%	26.93%	28.65%
Pre Tax Income Margin	32.61%	31.30%	24.26%	26.93%	29.45%	28.92%	28.82%	29.82%	31.05%	30.81%	32.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.22%	16.78%	17.97%	20.13%	23.48%	27.79%	27.42%	26.62%	25.87%	25.22%	23.95%
Augmented Payout Ratio	73.67%	71.03%	59.13%	64.84%	92.72%	112.80%	119.89%	100.89%	99.74%	96.23%	77.70%

Frequently Asked Questions About Lam Research's Financials

When does Lam Research's fiscal year end?

According to the most recent income statement we have on file, Lam Research's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has Lam Research's net income changed over the last 9 years?

Lam Research's net income appears to be on an upward trend, with a most recent value of $3.83 billion in 2024, rising from $655.58 million in 2015. The previous period was $4.51 billion in 2023. Find out what analysts predict for Lam Research in the coming months.

What is Lam Research's operating income?

Lam Research's total operating income in 2024 was $4.26 billion, based on the following breakdown:

Total Gross Profit: $7.05 billion
Total Operating Expenses: $2.79 billion

How has Lam Research revenue changed over the last 9 years?

Over the last 9 years, Lam Research's total revenue changed from $5.26 billion in 2015 to $14.91 billion in 2024, a change of 183.4%.

How much debt does Lam Research have?

Lam Research's total liabilities were at $10.21 billion at the end of 2024, a 3.5% decrease from 2023, and a 153.9% increase since 2015.

How much cash does Lam Research have?

In the past 9 years, Lam Research's cash and equivalents has ranged from $1.50 billion in 2015 to $5.85 billion in 2024, and is currently $5.85 billion as of their latest financial filing in 2024.

How has Lam Research's book value per share changed over the last 9 years?

Over the last 9 years, Lam Research's book value per share changed from 32.23 in 2015 to 65.32 in 2024, a change of 102.6%.

Related Companies

This page (NASDAQ:LRCX) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lam Research (LRCX) Financials

Frequently Asked Questions About Lam Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lam Research (LRCX) Financials

Annual Income Statements for Lam Research

Quarterly Income Statements for Lam Research

Annual Cash Flow Statements for Lam Research

Quarterly Cash Flow Statements for Lam Research

Annual Balance Sheets for Lam Research

Quarterly Balance Sheets for Lam Research

Annual Metrics and Ratios for Lam Research

Quarterly Metrics and Ratios for Lam Research

Frequently Asked Questions About Lam Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools